Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

Presentation TCT 2025

Update on CREST-2, or Update on Best Medical Management of Symptomatic and Asymptomatic Cervical Carotid Stenosis

Presenter: Edip Gurol

October 28, 2025

Presentation TCT 2024

Controversy in Asymptomatic Patients and What Role Will Be Played By CREST 2 Results

Presenter: Teresa Carman

October 29, 2024

Presentation ISET 2018

CREST 2 Registry: What Are We Learning?

Presenter: Kenneth Rosenfield

February 04, 2018

Presentation ISET 2018

Status of CREST-2: What Will It Tell Us and When

Presenter: Barry T. Katzen

February 04, 2018

Presentation ISET 2017

Update on the CREST 2 Trial

Presenter: Thomas G. Brott

February 06, 2017

Presentation ISET 2016

Understand CREST 2 and the Impact of the CREST 2 Registry

Presenter: Thomas Brott

February 07, 2016

Presentation TCT 2015

Debate: Is CREST-2 a Worthwhile Use of Precious Resources? Another Failed NIH-Funded Study: CREST-2 Is CORAL Redux (or Worse)!

Presenter: William A. Gray, D. Christopher Metzger

October 14, 2015

Presentation TCT 2015

Debate: Is CREST-2 a Worthwhile Use of Precious Resources? The CREST-2 Trial Is the Right Trial at the Right Time!

Presenter: William A. Gray, D. Christopher Metzger, Gary S. Roubin

October 14, 2015

Presentation ISET 2014

CREST 2: What Could It Tell Us?

Presenter: Thomas Brott

January 19, 2014

Presentation TCT 2013

CREST 2: Designed to Answer the Critical Questions About the Asymptomatic Carotid Patient

Presenter: Gary Roubin

October 28, 2013

Advertisement

Update on CREST-2, or Update on Best Medical Management of Symptomatic and Asymptomatic Cervical Carotid Stenosis

Controversy in Asymptomatic Patients and What Role Will Be Played By CREST 2 Results

CREST 2 Registry: What Are We Learning?

Status of CREST-2: What Will It Tell Us and When

Update on the CREST 2 Trial

Understand CREST 2 and the Impact of the CREST 2 Registry

Debate: Is CREST-2 a Worthwhile Use of Precious Resources? Another Failed NIH-Funded Study: CREST-2 Is CORAL Redux (or Worse)!

Debate: Is CREST-2 a Worthwhile Use of Precious Resources? The CREST-2 Trial Is the Right Trial at the Right Time!

CREST 2: What Could It Tell Us?

CREST 2: Designed to Answer the Critical Questions About the Asymptomatic Carotid Patient

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content